Dynamic prediction of cancer-associated thrombosis to guide prophylactic anticoagulation. Age distribution of metastatic cancer patients and chemotherapy discontinuation rates.
The semiconductor industry, as always, is at the forefront of transformational technological innovation, driving escalating complexity of manufacturing processes that extend time-to-market delivery, ...
Immunotherapy at the end of life. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results